glp-1 agonist dopamine for Weight Loss and Diabetes GLP1 — Research — Hayes
Description
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND)
Exenatide-associated ischemic renal failure
Individuals in both groups were more likely to be female and white
doi: 10.1007/s12291-009-0017-y 6
doi: 10.1161/CIRCULATIONAHA.124.067676 40 XiangJQinLZhongJXiaNLiangY
Not for human consumption, medical, or veterinary use.
